Results 201 to 210 of about 290,076 (302)

The landscape of data sources for marine harmful algal bloom-related disease surveillance in the Philippines, Malaysia and Indonesia: a systematic scoping review. [PDF]

UCL Open Environ
Morsella A, Alcantara Creencia L, Praptiwi RA, Scarsi N, Lombardi GS, Ricciardi W, Fleming LE, Cadeddu C, Gribble MO.   +8 more
europepmc   +1 more source

An ETH‐LAD trip with unfavourable consequences: A case report

British Journal of Clinical Pharmacology, EarlyView.
Numerous analogues of the psychedelic and internationally controlled hallucinogen LSD have been described; however, only a limited number have been systematically investigated. This report presents the first case with an analytically confirmed ingestion of ETH‐LAD (6‐ethyl‐6‐nor‐lysergic acid diethylamide), the N‐ethyl derivative of LSD.
Johannes Nadler, Michaela Sommer, Annette Zschiesche, Anne Stürzebecher, Christina Grumann, Volker Auwärter, Maren Hermanns‐Clausen   +6 more
wiley   +1 more source

Combined predictive value of dose, MODS, and NLR for lethal risk of diquat poisoning: a retrospective cohort study. [PDF]

Front Toxicol
Dai J, He M, Chen S, Chen Y, Li X, Ou H, Deng Y, Zhong C, Zeng W, Chen Y, Ruan Y, Wang Z, Ou Z.   +12 more
europepmc   +1 more source

"Mushroom" Poisoning [PDF]

BMJ, 1947
openaire   +5 more sources

Causality assessment tool for drug‐induced acute kidney injury in patients admitted to intensive care units: Requirements from a multicentre retrospective study in the Netherlands reusing data from electronic health records

British Journal of Clinical Pharmacology, EarlyView.
Aim This study aimed to provide key requirements for a drug‐induced acute kidney injury (d‐AKI) causality assessment tool (CAT) for intensive care unit (ICU) patients, using vancomycin‐induced AKI (v‐AKI) as a test case. Methods A retrospective review was conducted by medical experts of electronic health records of ICU patients from 14 Dutch ICUs.
Joanna E. Klopotowska, Izak A. R. Yasrebi‐de Kom, Nicolette F. de Keizer, Dave A. Dongelmans, on behalf of the RESCUE Study group, Merijn C. Reuland, Irma M. Rigter, Peter F. Schutte, Ilona T. Spaan, Dorieke van Balen, Stefaan Hendriks, Petronella E. Deetman, Cedric Lau, Wytze J. Vermeijden, Marieke G. J. Schouten, Joost B. Masselink, Peter E. Spronk, Marnix Kuindersma, Hendrikus J. M. van Kan, Anne Wellink, Abraham J. Valkenburg, Andre Wieringa, Walter M. van den Bergh, Maurits H. Renes, Wouter Bult, Frouke M. Engelaer, Nienke van Rein, Martijn Hoeksema, Janneke M. van den Broek, Elsbeth Wesselink, Ilse M. Purmer, Thomas Ottens, Bertha E. Bosma, Sjoerd H. W. van Bree, Barbara Festen, Hendrick J. W. Lammers, Rob J. Bosman, Rogier M. Determann, Eric J. F. Franssen, Attila Karakus, Lenneke. E. M. Haas, Freek van Gorp, Dylan W. de Lange, Maaike A. Sikma, Esther V. Uijtendaal   +44 more
wiley   +1 more source

Poisoning With Toxic Alcohols in Denmark. [PDF]

Basic Clin Pharmacol Toxicol
Jacobsen T, Huusom AJ, Petersen TS, Skaaby S, Hammer PEC.   +4 more
europepmc   +1 more source

Paediatric clonidine medication errors: Findings from a multicentre French study

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to describe the characteristics of medication errors involving clonidine in paediatric patients and reported to French Network of Pharmacovigilance and Poison Control Centres. Methods This retrospective observational study analysed clonidine‐related medication errors reported between 1985 and June 2024 in patients under 12 years ...
Eve‐Marie Thillard, Anthony Facile, Marion Lepelley, Morgane Cellier, Laurent Chouchana, Sophie Gautier, Ramy Azzouz, Thierry Vial, Annie‐Pierre Jonville‐Bera   +8 more
wiley   +1 more source

Hollow Silica/PUU Composites for Flame Retardancy and Blast Mitigation: From Shock Tube to In Vivo Protection

ACS Omega
Deming Huang, Jintao Xu, Zeng Huang, Juan Du, Zhuangqing Fan, Chu Gao, Ling Zeng, Jianxin Jiang, Hongwei Ruan, Anqiang Zhang   +9 more
doaj   +1 more source

A rare intravenous paraquat exposure presenting with novel and atypical severe clinical manifestations. [PDF]

Indian J Pharmacol
Patil VM, Inamdar SS, Jadhav NS, Mali DP.   +3 more
europepmc   +1 more source

THE ELIMINATION OF POISONS. [PDF]

The Lancet, 1871
openaire   +2 more sources